| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/21/2006 | EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/21/2006 | EP1670455A2 Treatment of diseases involving erbb2 kinase overexpression |
| 06/21/2006 | EP1670450A2 Pharmaceutical compositions and method of using levodopa and carbidopa |
| 06/21/2006 | EP1670428A2 G-csf transferrin fusion proteins |
| 06/21/2006 | EP1670425A2 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 06/21/2006 | EP1670417A2 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischenic mediated central nervous system disorders or injury |
| 06/21/2006 | EP1670415A2 Animal model for protease activity and liver damage |
| 06/21/2006 | EP1670414A2 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential |
| 06/21/2006 | EP1670315A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 06/21/2006 | EP1670314A2 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP1337279B1 Sterilisation of glucocorticosteriode suspensions |
| 06/21/2006 | CN1791602A 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 06/21/2006 | CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791580A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1791418A Nutrition replenisher for jucara and acai fruit group |
| 06/21/2006 | CN1791415A Pancreatic cancer treatment |
| 06/21/2006 | CN1791413A Anticancer compositions comprising methenamine |
| 06/21/2006 | CN1791403A Compositions and methods for treating cancer |
| 06/21/2006 | CN1791402A Ophthalmic compositions for treating ocular hypertension |
| 06/21/2006 | CN1791395A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791383A Self-emulsifying compositions, methods of use and preparation |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1259912C Citalopram for the treatment of elevated blood pressure |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064146 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| 06/20/2006 | CA2263404C Pharmaceutical composition comprising coenzyme q10 |
| 06/20/2006 | CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof |
| 06/15/2006 | WO2005120589A3 Contrast agent comprising alginate and an isotope or paramagnetic ion |
| 06/15/2006 | WO2005023176A3 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/15/2006 | WO2005013915A3 Novel indications for transforming growth factor-beta regulators |
| 06/15/2006 | WO2005011587A3 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
| 06/15/2006 | WO2004098519A3 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity |
| 06/15/2006 | WO2004019890A3 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 06/15/2006 | US20060129082 Selective plasma exchange therapy |
| 06/15/2006 | US20060129034 Medical decision support systems utilizing gene expression and clinical information and method for use |
| 06/15/2006 | US20060128812 Esterification of 2-[(diphenylmethyl)thio]acetic acid with an acyclic alcohol under reflux in the presence of an acid catalyst; amidation with ammonia; further oxidation with hydrogen peroxide produces Modafinil; central nervous system stimulant; narcolepsy |
| 06/15/2006 | US20060128792 Deguelin as a chemopreventive agent for lung cancer |
| 06/15/2006 | US20060128782 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 06/15/2006 | US20060128764 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/15/2006 | US20060128760 Use of mglur5 antagonists for the treatment of gerd |
| 06/15/2006 | US20060128699 Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions |
| 06/15/2006 | US20060128668 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060127967 In vitro test for studying compound predicting pharmacologic and/or harmacokinetic and/or pharmacodynamic parameters of a compound |
| 06/15/2006 | US20060127960 Process for preparation of an agglutination reagent for rapid detection of typhoid |
| 06/15/2006 | US20060127517 administering to mammal a composition comprising a first component selected from dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, a second component selected from the group consisting of rosemary, an extract derived from rosemary |
| 06/15/2006 | US20060127515 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 06/15/2006 | US20060127514 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 06/15/2006 | US20060127513 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 06/15/2006 | US20060127449 Method and composition for lowering cholesterol |
| 06/15/2006 | US20060127425 Encapsulated material released to generate perceivable sensorial indicia of discrete event occurrence |
| 06/15/2006 | US20060127423 Organic compounds |
| 06/15/2006 | US20060127416 Polynucleotide encoding a protein believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens. |
| 06/15/2006 | US20060127402 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/15/2006 | US20060127398 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 06/15/2006 | US20060127366 Method and device for inducing biological processes by micro-organs |
| 06/15/2006 | US20060127322 Stable pharmaceutical Budesonide preparation for producing propellant-free aerosols |
| 06/14/2006 | EP1669073A2 Fulvestrant formulation |
| 06/14/2006 | EP1668424A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 06/14/2006 | EP1668359A2 Heparin binding proteins: sensors for heparin detection |
| 06/14/2006 | EP1668145A2 SENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |
| 06/14/2006 | EP1668025A2 Seneca valley virus based compositions and methods for treating disease |
| 06/14/2006 | EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 06/14/2006 | EP1668002A2 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667983A2 Pyrazole modulators of metabotropic glutamate receptors |
| 06/14/2006 | EP1667979A2 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667978A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667735A2 Inhibition of inward sodium currents in cancer |
| 06/14/2006 | EP1667730A2 Compositions and methods for treating inflammatory lung disease |
| 06/14/2006 | EP1667729A2 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 06/14/2006 | EP1667718A2 Method of promoting graft survival with anti-tissue factor antibodies |
| 06/14/2006 | EP1667703A2 A composition and method of treatment for urogenital conditions |
| 06/14/2006 | EP1667701A2 Tumor vaccine |
| 06/14/2006 | EP1667695A2 Oligonucleotides targeting prion diseases |
| 06/14/2006 | EP1667683A2 Quinoline potassium channel inhibitors |
| 06/14/2006 | EP1667682A2 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 06/14/2006 | EP1667680A2 Combination methods of treating cancer |
| 06/14/2006 | EP1667674A2 A method of healing skin wounds in mammals and a composition therefor |
| 06/14/2006 | EP1667669A2 Inflammatory bowel diseases |
| 06/14/2006 | EP1667649A2 A dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 06/14/2006 | EP1667648A2 Compositions and methods for treating burns |
| 06/14/2006 | EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 06/14/2006 | EP1667646A2 Methods of using ammonia oxidizing bacteria |
| 06/14/2006 | EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1667634A2 Anthrax vaccine |
| 06/14/2006 | EP1667633A2 Polysaccharides for pulmonary delivery of active agents |
| 06/14/2006 | EP1667632A2 Treatment of severe distal colitis |
| 06/14/2006 | EP1667631A2 Combination approaches for generating immune responses |
| 06/14/2006 | EP1667630A2 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 06/14/2006 | EP1667601A2 Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
| 06/14/2006 | EP1667524A2 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/14/2006 | EP1667523A2 Dna vaccine compositions and methods of use |
| 06/14/2006 | EP1476136B1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation |
| 06/14/2006 | CN1788077A Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 06/14/2006 | CN1788008A 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists |